Get the Stockscreener App
1.405
0.71%
-0.005
Pmv Pharmaceuticals Inc stock is traded at $1.405, with a volume of 348.73K.
It is down -0.71% in the last 24 hours and down -2.78% over the past month.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
See More
Previous Close:
$1.41
Open:
$1.42
24h Volume:
348.73K
Relative Volume:
0.29
Market Cap:
$74.18M
Revenue:
-
Net Income/Loss:
$-51.47M
P/E Ratio:
-1.405
EPS:
-1
Net Cash Flow:
$-47.50M
1W Performance:
-11.39%
1M Performance:
-2.78%
6M Performance:
+40.48%
1Y Performance:
-14.11%
1-Day Range:
$1.38
$1.47
1-Week Range:
$1.38
$1.54
52-Week Range:
$0.81
$1.84
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
Name
Pmv Pharmaceuticals Inc
Sector
Industry
Phone
(609) 642-6670
Address
400 ALEXANDER PARK DRIVE, PRINCETON
Compare PMVP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.3999 | 74.72M | 0 | -51.47M | -47.50M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.60 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
640.26 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.99 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.15 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.40 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-08-24 | Upgrade | Oppenheimer | Perform → Outperform |
| May-13-24 | Initiated | Craig Hallum | Buy |
| Apr-12-24 | Initiated | Jefferies | Buy |
| Dec-27-23 | Initiated | Ladenburg Thalmann | Buy |
| Mar-02-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Sep-22-21 | Upgrade | Goldman | Neutral → Buy |
| Aug-19-21 | Initiated | Oppenheimer | Perform |
| Aug-02-21 | Initiated | Guggenheim | Buy |
| Jul-29-21 | Initiated | H.C. Wainwright | Buy |
| Oct-20-20 | Initiated | BofA Securities | Buy |
| Oct-20-20 | Initiated | Cowen | Outperform |
| Oct-20-20 | Initiated | Evercore ISI | Outperform |
| Oct-20-20 | Initiated | Goldman | Neutral |
View All
Pmv Pharmaceuticals Inc Stock (PMVP) Latest News
Is PMV Pharmaceuticals Inc. stock poised for growthWeekly Gains Summary & Weekly Watchlist for Consistent Profits - newser.com
PMV Pharmaceuticals Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView
Real time social sentiment graph for PMV Pharmaceuticals Inc.Breakout Watch & Daily Chart Pattern Signal Reports - newser.com
Using fundamentals and technicals on PMV Pharmaceuticals Inc.Weekly Investment Report & Free Growth Oriented Trading Recommendations - newser.com
PMV Pharmaceuticals Insider Stock Sellers Must Be Relieved As Market Cap Falls To US$75m - simplywall.st
Using AI based signals to follow PMV Pharmaceuticals Inc.Volume Spike & Comprehensive Market Scan Insights - newser.com
Is PMV Pharmaceuticals Inc. stock resilient to inflationPortfolio Gains Report & Step-by-Step Trade Execution Guides - newser.com
Will PMV Pharmaceuticals Inc. bounce back from current supportMarket Trend Summary & Verified Swing Trading Watchlists - newser.com
Published on: 2025-11-02 07:20:04 - newser.com
Published on: 2025-11-02 06:42:35 - newser.com
Applying chart zones and confluence areas to PMV Pharmaceuticals Inc.July 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - newser.com
Can PMV Pharmaceuticals Inc. stock deliver surprise earnings beatWeekly Gains Summary & Technical Entry and Exit Tips - newser.com
Will PMV Pharmaceuticals Inc. stock benefit from automationMarket Activity Report & Free Fast Gain Swing Trade Alerts - newser.com
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Sees Significant Growth in Short Interest - MarketBeat
Published on: 2025-11-01 11:39:40 - newser.com
Is PMV Pharmaceuticals Inc. building a consolidation baseWeekly Market Outlook & Entry Point Confirmation Signals - newser.com
What drives PMV Pharmaceuticals Inc stock priceTrade Execution Strategies & Small Budget Trading Plans - earlytimes.in
Orbimed Advisors LLC Reduces Stake in PMV Pharmaceuticals Inc - GuruFocus
How institutional buying supports PMV Pharmaceuticals Inc. stock2025 Big Picture & Accurate Entry and Exit Point Alerts - newser.com
PMV Pharmaceuticals (PMVP) Expected to Announce Earnings on Thursday - MarketBeat
PMV Pharmaceuticals (NASDAQ:PMVP) Major Shareholder Orbimed Advisors Llc Sells 1,000,000 Shares - MarketBeat
Is PMV Pharmaceuticals (NASDAQ:PMVP) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Can PMV Pharmaceuticals Inc. stock sustain market leadershipPortfolio Return Summary & Daily Oversold Bounce Ideas - fcp.pa.gov.br
How rising interest rates impact PMV Pharmaceuticals Inc. stockSell Signal & Daily Oversold Stock Bounce Ideas - newser.com
OrbiMed Advisors sells PMV Pharma (PMVP) shares for $1.52 million - Investing.com India
OrbiMed Advisors sells PMV Pharma (PMVP) shares for $1.52 million By Investing.com - Investing.com South Africa
Pmv Pharmaceuticals Inc Stock (PMVP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pmv Pharmaceuticals Inc Stock (PMVP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% Owner |
Oct 23 '25 |
Sale |
1.52 |
1,000,000 |
1,520,000 |
4,975,291 |
0.15%
1.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):